Old Web
English
Sign In
Acemap
>
authorDetail
>
Sen Zhuang
Sen Zhuang
Johnson & Johnson
Oncology
Cancer
Internal medicine
Medicine
Cancer research
2
Papers
29
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (2)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Assessment of Tumor Growth (g) and Regression (d) Rate Constants in Patients with Multiple Myeloma (MM) Shows That the Superiority of Bortezomib with Liposomal Doxorubicin (PLD+B) Over Bortezomib Alone (B) Is a Result of Reduced Growth of Refractory Tumor Cells and Not of Higher Regression Rates, and Provides An Earlier Efficacy Endpoint That Allows for Comparison Across Trials
2011
Blood
Elisabet Esteve Manasanch
Julia Wilkerson
Liang Xiu
Sen Zhuang
Susan E. Bates
Wilfred D. Stein
Antonio Tito Fojo
Show All
Source
Cite
Save
Citations (0)
A phase II clinical trial of ixabepilone (Ixempra; BMS-247550; NSC 710428), an epothilone B analog, in patients with metastatic renal cell carcinoma.
2010
Clinical Cancer Research
Hui Huang
Michael E. Menefee
Maureen Edgerly
Sen Zhuang
Herb Kotz
Marianne S. Poruchynsky
Lyn M. Huff
Susan E. Bates
Tito Fojo
Show All
Source
Cite
Save
Citations (29)
1